# The Dual Roles of Natural Cannabidiol in Combating Oxidative Stress and Inflammation: A Potential Intestinal Guardian

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabidiol-antioxidant-intestinal-protection/
> **Published:** 2026-04-27T05:03:41-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:02:07-04:00
> **Clinical Summary:** Explore cannabidiol antioxidant intestinal protection and its role in reducing oxidative stress and inflammation for gut health.

---

CED Clinical Relevance  #67Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
🔬 Evidence Watch  |  CED Clinic

Journal
Redox biology

Study Type
Clinical Study

Population
Human participants

Why This Matters

This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and clinical practice. Clinicians monitoring evidence in this area should review the source material.

Clinical Summary
Cannabidiol (CBD), a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L., has attracted increasing attention for its therapeutic potential in intestinal diseases. Accumulating evidence indicates that CBD exerts prominent antioxidant and [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) within the gastrointestinal tract. Oxidative stress and redox imbalance are key drivers of epithelial barrier dysfunction, chronic inflammation, and disease progression in disorders such as inflammatory bowel disease (IBD) and colorectal cancer (CRC). This review focuses on the redox-related mechanisms underlying CBD’s intestinal protective actions, highlighting its ability to regulate reactive oxygen species (ROS) production, activate the Nrf2-Keap1 antioxidant pathway, and modulate redox-sensitive inflammatory signaling, including NF-κB and the NLRP3 inflammasome. In parallel, CBD engages the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) (ECS) and related receptors to preserve epithelial barrier integrity, regulate g

Dr. Caplan’s Take

“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”

Clinical Perspective
🧠 Clinicians should review this item in the context of their current practice and patient population.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20dual%20roles%20of%20natural%20cannabidiol%20in%20combating%20oxidative%20stress%20and%20inflammation%3A%20A%20potential%20in...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fthe-dual-roles-of-natural-cannabidiol-in-combating-oxidative-stress-and-inf%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fthe-dual-roles-of-natural-cannabidiol-in-combating-oxidative-stress-and-inf%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20dual%20roles%20of%20natural%20cannabidiol%20in%20combating%20oxidative%20stress%20and%20inflammation%3A%20A%20potential%20in...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fthe-dual-roles-of-natural-cannabidiol-in-combating-oxidative-stress-and-inf%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41713221/](https://pubmed.ncbi.nlm.nih.gov/41713221/)

Table of Contents

- [FAQ](#FAQ)[What does this review say about CBD and the intestines?](#What_does_this_review_say_about_CBD_and_the_intestines)
- [Why does oxidative stress matter in bowel diseases like IBD?](#Why_does_oxidative_stress_matter_in_bowel_diseases_like_IBD)
- [How might CBD protect the intestine according to this review?](#How_might_CBD_protect_the_intestine_according_to_this_review)
- [Is the CBD discussed in this review psychoactive or addictive?](#Is_the_CBD_discussed_in_this_review_psychoactive_or_addictive)
- [Related](#Related)

## FAQ

### What does this review say about CBD and the intestines?

The review states that accumulating evidence indicates CBD has prominent antioxidant and [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) within the gastrointestinal tract. It focuses on the redox-related mechanisms that may underlie CBD’s protective actions in the intestine. It was published in the journal Redox Biology.

### Why does oxidative stress matter in bowel diseases like IBD?

According to the review, oxidative stress and redox imbalance are key drivers of epithelial barrier dysfunction, chronic inflammation, and disease progression. It names inflammatory bowel disease (IBD) and colorectal cancer (CRC) as examples of such disorders. This link helps explain why the review focuses on redox-related mechanisms of CBD’s protective effects.

### How might CBD protect the intestine according to this review?

The review highlights several proposed mechanisms. CBD may regulate production of reactive oxygen species, activate the Nrf2-Keap1 antioxidant pathway, and modulate redox-sensitive inflammatory signaling such as NF-κB and the NLRP3 inflammasome. CBD also engages the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and related receptors to help preserve the integrity of the epithelial barrier.

### Is the CBD discussed in this review psychoactive or addictive?

The review describes cannabidiol, or CBD, as a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L. It notes that CBD has attracted increasing attention for its therapeutic potential in intestinal diseases, which is the focus of this review.

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/)

Explore emerging evidence on cannabinoids including CBD and CBG in improving [liver health](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) and metabolic conditions.

[Learn More](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/)

[Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/)

Review clinical findings on how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) can reduce reliance on opioids and prescription medications.

[Read Study](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/)

[You have heard that cannabis helps with nausea and anxiety during cancer treatment … – Instagram](https://cedclinic.com/cannabis-nausea-anxiety-cancer-treatment-insights/)

Understand patient experiences and clinical insights on cannabis use for nausea and anxiety in cancer care.

[Explore Insights](https://cedclinic.com/cannabis-nausea-anxiety-cancer-treatment-insights/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).